Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hovind

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 2001
Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1P Hovind, L Tarnow, P Rossing, et al.
Archives of Osteoporosis|August 16, 2024
Sarcopenia and self-reported markers of physical frailty in patients with osteoporosisB R Nielsen, H E Andersen, P Hovind, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2009
Rapid decline in 51Cr-EDTA measured renal function during the first weeks following lung transplantationM Hornum, M Iversen, I Steffensen, et al.
Diabetes/Metabolism Research and Reviews|March 18, 2017
Incident microalbuminuria and complement factor mannan-binding lectin-associated protein 19 in people with newly diagnosed type 1 diabetesJ A Østergaard, S Thiel, I T Hoffmann-Petersen, et al.
Diabetes, Obesity & Metabolism|June 30, 2009
Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetesS S Lund, L Tarnow, A S Astrup, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 22, 2020
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-studyM Piazza, N M J Hanssen, F Persson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 21, 2022
Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker studyS E Bønløkke, M S Rand, B Haddock, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 2001
Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1P Hovind, L Tarnow, P Rossing, et al.
Archives of Osteoporosis|August 16, 2024
Sarcopenia and self-reported markers of physical frailty in patients with osteoporosisB R Nielsen, H E Andersen, P Hovind, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2009
Rapid decline in 51Cr-EDTA measured renal function during the first weeks following lung transplantationM Hornum, M Iversen, I Steffensen, et al.
Diabetes/Metabolism Research and Reviews|March 18, 2017
Incident microalbuminuria and complement factor mannan-binding lectin-associated protein 19 in people with newly diagnosed type 1 diabetesJ A Østergaard, S Thiel, I T Hoffmann-Petersen, et al.
Diabetes, Obesity & Metabolism|June 30, 2009
Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetesS S Lund, L Tarnow, A S Astrup, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 22, 2020
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-studyM Piazza, N M J Hanssen, F Persson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 21, 2022
Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker studyS E Bønløkke, M S Rand, B Haddock, et al.
Pageof 2